0001974158-24-000037.txt : 20240513 0001974158-24-000037.hdr.sgml : 20240513 20240513160635 ACCESSION NUMBER: 0001974158-24-000037 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240513 DATE AS OF CHANGE: 20240513 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC CENTRAL INDEX KEY: 0001810182 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 850642577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39386 FILM NUMBER: 24939034 BUSINESS ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-466-7125 MAIL ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Randolph Sophia CENTRAL INDEX KEY: 0001817127 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ALX ONCOLOGY HOLDINGS INC. STREET 2: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 144 1 primary_doc.xml 144 0001817127 XXXXXXXX LIVE 0001810182 ALX ONCOLOGY HOLDINGS INC 001-39386 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125 Randolph Sophia Officer Common Jefferies LLC

520 Madison Avenue 4th Floor New York NY 10022

78000 1264380.00 52100000 05/13/2024 NASDAQ Common 11/10/2016 Restricted stock ALX Oncology Holdings Inc N 78000 11/10/2016 N/A Y All Sales are to be made pursuant to a previously signed/adopted 10b5-1 selling plan dated 01/11/2024 and all representations regarding material non-public information were made as of the adoption of the plan. 05/13/2024 01/11/2024 Sophia Randolph